PFM Health Sciences’s Progressive PGR Stock Holding History

PFM Health Sciences’s Portfolio PGR Stock Details PGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-653,485	Closed	-$52.2M	–	95
2019 Q2	$52.2M	Buy	+653,485	New	+$50.5M	0.99%	37

Other funds holding PGR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PFM Health Sciences's PGR Position: Q3 2019 in Review

PFM Health Sciences sold out of Progressive (PGR) in Q3 2019, closing a stake of 653,485 shares — an estimated $52.2M sold.

PFM Health Sciences first reported a position in PGR in Q2 2019 and held it in 1 quarter. The position peaked at $52.2M in Q2 2019. 881 funds tracked by Wall St. Rank hold PGR as of Q3 2019.

PFM Health Sciences reported no remaining Progressive position as of Q3 2019 after selling out during the quarter.
PFM Health Sciences sold 653,485 Progressive shares in Q3 2019, an estimated $52.2M.
PFM Health Sciences first reported a position in Progressive in Q2 2019 and held it in 1 quarter.
PFM Health Sciences's Progressive position peaked at $52.2M in Q2 2019.
881 funds tracked by Wall St. Rank held Progressive as of Q3 2019.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.